Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

Every couple of years it seems like another wave of stories emerge claiming picking your nose is a major causal factor in the ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...

Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to ...

If you live with or take care of someone with dementia or Alzheimer's disease, you know interactions with strangers in public can be a challenge.

PITTSBURGH (KDKA) — A breakthrough in the fight against Alzheimer's was made by researchers at the University of Pittsburgh, where a test was created to detect the disease in the brain earlier.

Alzheimer’s is a devastating brain disease that affects nearly seven million Americans. But sometimes, it’s misdiagnosed.

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...